Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma.
Zheng Y, Wang J, Zhao G, Zhang Z, Shao Y, Lu B, Zhang Y, Chen R, Sun L, Xie X, Ding J, Zheng J, Chai D.
Zheng Y, et al. Among authors: ding j.
J Immunother Cancer. 2025 Jan 4;13(1):e010521. doi: 10.1136/jitc-2024-010521.
J Immunother Cancer. 2025.
PMID: 39755580